Recent Cox-2 inhibitor use increased ischemic stroke mortality risk

10.12.20141416
The use of cyclooxygenase-2 inhibitors before hospitalization for stroke is associated with increased mortality in cases of ischemic stroke, but not hemorrhagic stroke, according to recent findings.

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

08.12.20141584
Experimental data indicate that reducing factor XI levels attenuates thrombosis without causing bleeding, but the role of factor XI in the prevention of postoperative venous thrombosis in humans is unknown. FXI-ASO (ISIS 416858) is a second-generation antisense oligonucleotide that specifically reduces factor XI levels.

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study

05.12.20141648
Does aggressive risk factor management (RFM) improve outcomes after catheter ablation of atrial fibrillation (AF)?

Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction

04.12.20141895
What are the comorbidities associated with heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF)?

Вебинары Европейского общества кардиологов

03.12.20142353
Приглашаем Вас принять участие в бесплатных вебинарах Европейского общества кардиологов.

Rosuvastatin failed to reduce fracture risk in JUPITER analysis

03.12.20141647
Rosuvastatin was not associated with a reduced risk for fracture in men and women with elevated high-sensitivity C-reactive protein enrolled in the JUPITER trial.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.